Template:Neonatal conjunctivitis treatment: Difference between revisions
(Created page with "*Azithromycin 20mg/kg PO once daily x 3 days OR *Erythromycin 50mg/kg PO QD in 4 divided doses x 14 days") |
No edit summary |
||
| Line 1: | Line 1: | ||
===[[Gonococcal]]=== | |||
*Cefotaxime 100mg/kg IV or IM OR [[ceftriaxone]] 25-50mg/kg IV or IM x1 (not to exceed 125mg) | |||
**Cefotaxime is preferred because it does not displace bilirubin | |||
**Disseminated disease should be suspected until CSF is negative | |||
**Topical treatment is unnecessary | |||
===[[Chlamydia]]=== | |||
*[[Azithromycin]] 20mg/kg PO once daily x 3 days OR | *[[Azithromycin]] 20mg/kg PO once daily x 3 days OR | ||
*[[Erythromycin]] 50mg/kg PO QD in 4 divided doses x 14 days | *[[Erythromycin]] 50mg/kg PO QD in 4 divided doses x 14 days | ||
**Disease manifests 5 days post-birth to 2 weeks (late onset) | |||
*Topical treatment is unnecessary | |||
===[[Herpetic]]=== | |||
*Acyclovir 20mg/kg IV q8hr x 14-21d | |||
*Topical antiviral | |||
*Full sepsis evaluation | |||
Revision as of 20:12, 20 May 2015
Gonococcal
- Cefotaxime 100mg/kg IV or IM OR ceftriaxone 25-50mg/kg IV or IM x1 (not to exceed 125mg)
- Cefotaxime is preferred because it does not displace bilirubin
- Disseminated disease should be suspected until CSF is negative
- Topical treatment is unnecessary
Chlamydia
- Azithromycin 20mg/kg PO once daily x 3 days OR
- Erythromycin 50mg/kg PO QD in 4 divided doses x 14 days
- Disease manifests 5 days post-birth to 2 weeks (late onset)
- Topical treatment is unnecessary
Herpetic
- Acyclovir 20mg/kg IV q8hr x 14-21d
- Topical antiviral
- Full sepsis evaluation